sorafenib has been researched along with oxadiazoles in 3 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (oxadiazoles) | Trials (oxadiazoles) | Recent Studies (post-2010) (oxadiazoles) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 6,057 | 257 | 2,359 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abdel-Maksoud, MS; El-Gamal, MI; Gamal El-Din, MM; Oh, CH; Yoo, KH | 1 |
Kadastik, Ü; Lavogina, D; Lavrits, A; Meltsov, A; Peters, M; Rinken, A; Salumets, A; Samuel, K; Sõritsa, D | 1 |
Asai, A; Asakawa, N; Hirata, G; Kurita, A; Nishisaka, F; Ogo, N; Shishido, Y; Takagi, A; Takahashi, H; Taniguchi, K; Tsugane, M | 1 |
3 other study(ies) available for sorafenib and oxadiazoles
Article | Year |
---|---|
Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Niacinamide; Oxadiazoles; Phenylurea Compounds; Sorafenib; Structure-Activity Relationship; Urea | 2015 |
Chemosensitivity and chemoresistance in endometriosis - differences for ectopic versus eutopic cells.
Topics: Adult; Aminobenzoates; Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Doxorubicin; Drug Resistance; Endometriosis; Endometrium; Epithelial Cells; Female; Humans; Necrosis; Oligopeptides; Oxadiazoles; Peritoneal Diseases; Sorafenib; Stromal Cells; Young Adult | 2019 |
Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Humans; Interleukin-6; Mice; Molecular Docking Simulation; Mouth Neoplasms; Oxadiazoles; Protein Multimerization; Quinolines; Signal Transduction; Sorafenib; src Homology Domains; STAT3 Transcription Factor; Survivin; Xenograft Model Antitumor Assays | 2020 |